"Empowering surgeons with autonomous precision"
South San Francisco startup developing AI-powered autonomous surgical robots for endourology, starting with robotic HoLEP for benign prostatic hyperplasia.
Andromeda Surgical is a South San Francisco, California-based surgical robotics company founded in 2023 by Nick Damiano (CEO) and Kartik Tiwari (CTO). The company is developing an AI-powered autonomous surgical robot platform targeting endourology, beginning with holmium laser enucleation of the prostate (HoLEP) for treatment of benign prostatic hyperplasia. The system combines AI guidance with off-the-shelf robotic arms, controlled via a tablet interface, to deliver world-expert-level surgical precision and reduce the steep learning curve associated with complex endourological procedures.
In December 2024, Andromeda conducted the world's first robotic-assisted HoLEP procedure at Universidad Católica in Chile, initiating its ASTRA clinical trial. By early 2025, 15 successful procedures had been completed across Chile and New Zealand. The company announced strategic partnerships with endoscopy specialist Richard Wolf and laser company Quanta System in March 2025.
Andromeda is backed by Y Combinator and Attack Capital. Co-founder Damiano previously founded Zenflow and Avail MedSystems; Tiwari co-founded Starsky Robotics.
Primary type & automation activities this supplier delivers:
AI-guided autonomous robotic platform for holmium laser enucleation of the prostate (HoLEP), controlled via tablet and designed to deliver expert-level outcomes in BPH surgery.
Contact Andromeda Surgical
WEBSITE
https://andromedasurgical.comHEADQUARTERS
United States
Company Facts
Founded
2023
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-